Error loading player: No playable sources found
36756
Session IV - Emerging Technologies
Date
June 7, 2022
This product is not available for individual purchase, but it is available as part of the following products:
The Cell and Gene Therapy Products (CGTP) Symposium: Manufacturing, Quality and Regulatory Considerations enables the exchange of scientific ideas and dialogue with regulators that form the basis of evolving regulatory practices in the development of these diverse and innovative products…
In recent years, cell and gene therapies have evolved rapidly into approved products for the treatment of both incurable genetic diseases as well as for the treatment of certain cancers. Emerging technologies such as the design of new experimental vectors, use of pluripotent and allogenic cells, improvements in efficacy and specificity of the delivery systems, and the greater understanding of the inflammatory response against these modalities are leading to the expansion of clinical applications in this space. This session will explore examples of emerging molecular and cellular approaches that are tackling the challenges with the current therapeutic options in gene and cell therapy and building the next generation of sophisticated approaches to treating diseases.
Session Chairs
Related Products
Session VI - Cell Therapies
The Cell Therapies products space is continuing to build on the potential for innovative treatments for unmet patient needs. Topics include cell products with unique manufacturing process, complex sourcing starting material, and assays with direct relevance to CQAs…
Session II - Managing the Complexity of the CGTP Supply Chain
Cell, gene, and other novel therapies require carefully designed and well executed logistics solutions for supplying lifesaving medicine to patients…
